Free Trial

Sight Sciences (SGHT) Stock Forecast & Price Target

$6.56
-0.27 (-3.95%)
(As of 09/18/2024 ET)

Sight Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 5 Wall Street analysts who have issued ratings for Sight Sciences in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a buy rating for SGHT.

Consensus Price Target

$7.25
10.52% Upside
High Forecast$10.00
Average Forecast$7.25
Low Forecast$6.00

According to the 5 analysts' twelve-month price targets for Sight Sciences, the average price target is $7.25. The highest price target for SGHT is $10.00, while the lowest price target for SGHT is $6.00. The average price target represents a forecasted upside of 10.52% from the current price of $6.56.

TypeCurrent Forecast
9/20/23 to 9/19/24
1 Month Ago
8/21/23 to 8/20/24
3 Months Ago
6/22/23 to 6/21/24
1 Year Ago
9/20/22 to 9/20/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$7.25$5.70$4.70$4.60
Forecasted Upside10.52% Upside-3.09% Downside5.90% Upside-0.99% Downside

SGHT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SGHT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sight Sciences Stock vs. The Competition

TypeSight SciencesMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.77
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside10.52% Upside1,006.91% Upside7.94% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/21/2024Lake Street Capital
3 of 5 stars
F. Takkinen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00+64.47%
8/2/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingHold
7/15/2024Morgan Stanley
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$5.40 ➝ $6.50-14.25%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$6.00 ➝ $6.50+5.69%
5/3/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$5.00 ➝ $6.00+4.90%
9/18/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$11.00 ➝ $5.00+44.93%
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
9/12/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$10.00 ➝ $4.50-30.88%
9/12/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kaczor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:32 AM ET.

SGHT Forecast - Frequently Asked Questions

What is Sight Sciences' forecast for 2024?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Sight Sciences is $7.25, with a high forecast of $10.00 and a low forecast of $6.00.

Should I buy or sell Sight Sciences stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SGHT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGHT, but not buy additional shares or sell existing shares.

Does Sight Sciences's stock price have much upside?

According to analysts, Sight Sciences's stock has a predicted upside of 13.59% based on their 12-month stock forecasts.

What analysts cover Sight Sciences?

Sight Sciences has been rated by research analysts at Citigroup, Lake Street Capital, Morgan Stanley, and Needham & Company LLC in the past 90 days.

Do Wall Street analysts like Sight Sciences more than its competitors?

Analysts like Sight Sciences less than other "medical" companies. The consensus rating for Sight Sciences is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SGHT compares to other companies.



This page (NASDAQ:SGHT) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners